The Office of Developmental Programs (ODP) has released the sixteenth in a series of its quarterly publication QM Spotlight. This issue focuses on the QA&I Self-Assessment and how to use it well, so that the QA&I process becomes predictable, manageable, and an opportunity – not a surprise.
The Office of Developmental Programs (ODP) has shared ODPANN 26-002. The purpose of this communication is to provide guidance regarding the intent and purpose of an Individual Support Plan (ISP) meeting and whether attending an ISP meeting is a billable unit of service.
Please view the announcement for more details. Questions about this announcement should be directed to the appropriate ODP BSASP Regional Office.
Dexcom Issues Correction for Dexcom G6 and G6 Pro Software:
This recall involves correcting devices and does not involve removing the devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction.
Affected Product
What to Do
Upgrade from app version 1.15.0 as soon as possible.
On September 18, Dexcom Inc. sent all affected customers an Urgent Medical Device Correction message recommending the following actions:
Reason for Correction
Dexcom Inc. is correcting the Dexcom G6 Continuous Glucose Monitoring System’s G6 and G6 Pro Android US CGM App version 1.15.0 due to an identified bug that can cause the app to terminate unexpectedly. As a result, the user may not receive estimated glucose values, alarms, or alerts. If a user is unaware that the app has terminated, there is potential for missed detection of a high blood sugar (hyperglycemic) or low blood sugar (hypoglycemic) event.
The use of affected product may cause serious adverse health consequences, including hyperglycemia, hypoglycemia, and death.
As of September 16, Dexcom has not reported any serious injuries or deaths associated with this issue.
Device Use
The Dexcom G6 Continuous Glucose Monitoring System is a real-time continuous glucose monitoring system that sends glucose readings to a compatible smart device or the Dexcom receiver every five minutes. The Dexcom G6 and G6 Pro Android US CGM App is an application for compatible smart devices that displays glucose levels and trends.
Contact Information
Customers in the U.S. with questions about this recall should contact Dexcom Technical Support at 1-844-478-1600.
Additional FDA Resources
Unique Device Identifier (UDI)
The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly.
How do I report a problem?
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.
On July 1, 2025, the Bureau of Supports for Autism and Special Populations (BSASP) rolled out a new assessment bundle for the Adult Autism Waiver (AAW). The Office of Developmental Programs (ODP) is interested in hearing from Supports Coordinators (SC) and providers on their experiences with implementing the new assessments.
Please join ODP for a Virtual Office Hour (VOH) to share feedback, ask questions, and review resource materials.
Who should attend?
All AAW SCs and Providers
Date: January 30, 2026
Time: 10:00 am – 11:30 am
Register Here
The Office of Developmental Programs (ODP) has shared ODPANN 25-117. This communication is intended to inform all interested parties of the Office of Developmental Programs (ODP) publication of updated versions of the Intellectual Disability/Autism (ID/A) Employment Services Definition Question and Answer (Q&A) and the Employment Service Definition Quick Guide for ID/A Waivers and Base-Funded Participants.
NOTE: The release of this communication obsoletes ODP Announcement 19-025 – Now Available Updated ID/A Waiver Employment Service Definition Question and Answer Document and ID/A Waiver Employment Service Definition Quick Guide.
Please review the announcement for more details.
ATTACHMENTS:
The Department of Human Services’ (DHS) Office of Mental Health & Substance Abuse Services (OMHSAS) and the Office of Developmental Programs (ODP) host a quarterly Statewide Positive Approaches & Practices meeting. This meeting aims to provide the most recent research and resources for people with mental health and behavioral challenges, intellectual disabilities, autism, and other developmental disabilities to live an everyday life.
The next meeting is scheduled for Thursday, January 15, 2026, from 8:30 am – 10:30 am and 1:00 pm – 3:00 pm. The topic for the morning session is “The Foundation is Communication.” The topic for the afternoon session is “Sensory or Behavior? Diving into Sensory Processing.” This meeting will be held online via Zoom.
Please see the announcement for additional information.
The Zoom link for joining the session will be sent to the email you used to register. This link will be unique to your registration. Please do not share this link.
Questions? Email PATraining.
The Office of Developmental Programs (ODP) has shared ODPANN 25-116. The purpose of this communication is to inform providers of Adult Autism Waiver (AAW) services and Supports Coordination Organizations (SCO) of the updated provider qualification process.
The Centers for Medicare and Medicaid Services (CMS) require a statewide process to ensure providers are qualified to render services to waiver-funded individuals. The Provider Qualification Process described in the communication outlines the steps the provider must follow to meet these requirements, and the steps Supports Coordinators (SC) must take to transition individuals if needed. This communication does not describe the qualification process for AAW SCOs.
NOTE: The release of this communication obsoletes ODP Announcement 20-110 New Adult Autism Waiver (AAW) Provider Qualification Process.
Providers that are shared across Intellectual Disability/Autism (ID/A) and the AAW must complete the Provider Qualification processes with both their assigned Administrative Entity (AE) for the ID/A waivers and the Bureau of Supports for Autism and Special Populations (BSASP) for the AAW.
Please view the full announcement for complete details.
The Office of Developmental Programs (ODP) has shared ODPANN 25-114. This communication notifies all interested parties of the recorded webinar that explained the January 2026 Waiver Amendments. This webinar and is now posted on the MyODP website.
The webinar contains a brief high-level overview of Performance-Based Contracting as well as changes not related to Performance-Based Contracting that impact ODP’s Consolidated, Community Living, and Person/Family Directed Supports (P/FDS) waivers.
Please review the announcement for more details.
The Office of Developmental Programs (ODP) has shared ODPANN 25-113. This communication includes an updated version of the Intellectual Disability/Autism (ID/A) Individual Support Plan Signature Form (DP 1032) that was released with the ODP Announcement 25-012: Updates to the Individual Support Plan (ISP) Bulletin Attachments. After the release, ODP was informed that the MCI Number and the individual’s name needed to be added to each page of the form. This form has also been translated into Spanish.
The revised and translated forms may be found on the MyODP Forms page.
Questions about this communication should be directed to the appropriate Office of Developmental Programs Regional Office.
Please share these important workshops and support groups with your networks! Register for upcoming events at PA Family Network’s website.
Good Life Group, Support Groups
LifeCourse Workshops
Waiver Workshops
